Acadia Healthcare Company, Inc. $ACHC Shares Sold by UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC cut its holdings in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 19.2% during the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 222,444 shares of the company’s stock after selling 52,869 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.24% of Acadia Healthcare worth $6,569,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in ACHC. BlackRock Inc. purchased a new stake in shares of Acadia Healthcare in the second quarter valued at about $441,685,000. Wellington Management Group LLP increased its stake in shares of Acadia Healthcare by 24.9% during the 4th quarter. Wellington Management Group LLP now owns 11,774,308 shares of the company’s stock worth $167,077,000 after purchasing an additional 2,350,760 shares in the last quarter. Goldman Sachs Group Inc. raised its position in shares of Acadia Healthcare by 417.8% during the 4th quarter. Goldman Sachs Group Inc. now owns 4,728,613 shares of the company’s stock worth $67,099,000 after purchasing an additional 3,815,471 shares during the last quarter. UBS Group AG lifted its stake in Acadia Healthcare by 8.8% in the 3rd quarter. UBS Group AG now owns 4,336,698 shares of the company’s stock valued at $107,377,000 after buying an additional 350,484 shares in the last quarter. Finally, Jefferies Financial Group Inc. acquired a new stake in Acadia Healthcare during the 2nd quarter valued at $106,458,000.

Acadia Healthcare Price Performance

ACHC stock opened at $27.50 on Wednesday. The stock has a market capitalization of $2.56 billion, a price-to-earnings ratio of -2.21, a price-to-earnings-growth ratio of 9.06 and a beta of 0.62. The company has a quick ratio of 1.57, a current ratio of 1.57 and a debt-to-equity ratio of 1.20. Acadia Healthcare Company, Inc. has a 52-week low of $11.43 and a 52-week high of $35.83. The stock’s fifty day simple moving average is $30.67 and its 200-day simple moving average is $26.74.

Acadia Healthcare (NASDAQ:ACHC) last released its earnings results on Tuesday, July 28th. The company reported $0.38 earnings per share for the quarter, topping the consensus estimate of $0.35 by $0.03. The firm had revenue of $865.84 million for the quarter, compared to the consensus estimate of $844.19 million. Acadia Healthcare had a positive return on equity of 6.19% and a negative net margin of 33.44%.The firm’s revenue for the quarter was down .4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.83 earnings per share. Acadia Healthcare has set its FY 2026 guidance at 1.450-1.600 EPS. Equities research analysts expect that Acadia Healthcare Company, Inc. will post 1.55 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on the company. Guggenheim boosted their price target on Acadia Healthcare from $38.00 to $39.00 and gave the stock a “buy” rating in a report on Thursday, July 30th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Acadia Healthcare in a research note on Friday, June 12th. KeyCorp boosted their target price on shares of Acadia Healthcare from $30.00 to $40.00 and gave the company an “overweight” rating in a research note on Tuesday, July 14th. Barclays upped their target price on shares of Acadia Healthcare from $25.00 to $32.00 and gave the company an “equal weight” rating in a report on Thursday, July 30th. Finally, Cantor Fitzgerald reiterated a “neutral” rating on shares of Acadia Healthcare in a report on Wednesday, July 29th. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, five have assigned a Hold rating and two have given a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average price target of $29.85.

Acadia Healthcare Profile

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.